As of 2026-09-21, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (51.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -9548.3%.
The range of the Relative Valuation is (36.79) - (55.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 32.0x | 22.4x |
| Forward P/E multiples | 14.5x - 21.6x | 18.5x |
| Fair Price | (36.79) - (55.06) | (51.97) |
| Upside | -6788.9% - -10110.3% | -9548.3% |
| Date | P/E |